Internationally recognized for his expertise in hepatic cancer, Dr. Jeff Geschwind has shaped Interventional Oncology into a major medical specialty. With leadership roles at NAMSA and USA Clinics Group, he continues to drive cutting-edge innovations in tumor targeting, cancer drug development, and image-guided treatment systems. https://www.bumc.bu.edu/camed/offices-services/alumni/alumni-recognition-resources/alumni-awards-submission/past-recipients-of-the-alumni-awards/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/